Hansa Biopharma AB “Hansa”, a pioneer in enzyme technology for rare immunological conditions, announced the release of the Annual Report 2022.
Hansa Biopharma AB “Hansa”, a pioneer in enzyme technology for rare immunological conditions, announced the release of the Annual Report 2022.